학술논문
947P Updated survival and secondary safety and efficacy analyses from CA 209-678: A phase II open-label single-centre study of Y90-radioembolisation (Y90) in combination with nivolumab in Asian patients (pts) with advanced hepatocellular carcinoma (aHCC)
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S825-S825
Subject
Language
ISSN
0923-7534